These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1210328)

  • 1. Termination of hypertensive pregnancies with intra-amniotic urevert.
    Roopnarinesingh S
    West Indian Med J; 1975 Sep; 24(3):164-8. PubMed ID: 1210328
    [No Abstract]   [Full Text] [Related]  

  • 2. Intrauterine PGF2 alpha infusion for termination of pregnancies with second-trimester rupture of membranes.
    Jaschevatzky OE; Dascalu S; Noy Y; Rosenberg RP; Anderman S; Ballas S
    Obstet Gynecol; 1992 Jan; 79(1):32-4. PubMed ID: 1727581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Termination of midtrimester pregnancy by intramniotic injection of urea.
    Anteby SO; Segal S; Polishuk WZ
    Obstet Gynecol; 1974 May; 43(5):765-8. PubMed ID: 4822662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of midtrimester abortion with intra-amniotic urea and intravenous oxytocin.
    Smith WG; Allen HH; Collins JA; Roth J
    Am J Obstet Gynecol; 1977 Feb; 127(3):228-31. PubMed ID: 835617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of extra-amniotic prostaglandin F2 alpha infusion and increasing intravenous oxytocin for termination of second trimester missed abortion.
    Jaschevatzky OE; Rosenberg RP; Noy Y; Dascalu S; Anderman S; Ballas S
    J Am Coll Surg; 1994 May; 178(5):435-8. PubMed ID: 8167879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second trimester amniotic fluid endothelin concentration. A possible predictor for pre-eclampsia.
    Margarit L; Griffiths A; Tsapanos V; Decavalas G; Gumenos D
    J Obstet Gynaecol; 2005 Jan; 25(1):18-20. PubMed ID: 16147686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oxytocin and misoprostol administered intravaginally for termination of pregnancy at 13 to 29 weeks of amenorrhea. A prospective randomized trial].
    Hidar S; Fekih M; Chaïeb A; Bibi M; Mellouli R; Khaïri H
    J Gynecol Obstet Biol Reprod (Paris); 2001 Sep; 30(5):439-43. PubMed ID: 11598557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Induction of therapeutic abortion by intra-amniotic and intravenous administration of prostaglandin F2-alpha in the second trimester of pregnancy].
    Otoka A; Otoka K
    Wiad Lek; 1982 Sep; 35(15-16):969-72. PubMed ID: 6959421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Termination of mid-trimester pregnancy by transcervical extra-amniotic hypertonic saline method without in-dwelling catheter.
    Nummi S; Pystynen P
    Ann Chir Gynaecol Fenn; 1974; 63(6):479-82. PubMed ID: 4441028
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of extra- and intra-amniotic prostaglandins for therapeutic abortion.
    Fraser IS; Brash JH
    Obstet Gynecol; 1974 Jan; 43(1):97-103. PubMed ID: 4808969
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypertensive diseases of pregnancy.
    Matadial L; Grell GA; Walker G; Forrester TE
    West Indian Med J; 1985 Dec; 34(4):225-33. PubMed ID: 4090467
    [No Abstract]   [Full Text] [Related]  

  • 12. [Quantitative changes of the chemical constituents of the amniotic fluid in normal and pathological pregnancies (bibliographic review)].
    Ghigbuh AE
    Ann Ostet Ginecol Med Perinat; 1973; 94(7-8):535-46. PubMed ID: 4804945
    [No Abstract]   [Full Text] [Related]  

  • 13. [Abortion-inducing effect of intravenously administered PGF-2alpha and oxytocin in normal pregnancy and pregnancy complications (author's transl)].
    Szabó E; Jaszmann L; Szontágh FE
    Zentralbl Gynakol; 1974 Aug; 96(35):1103-10. PubMed ID: 4440309
    [No Abstract]   [Full Text] [Related]  

  • 14. Amniotic fluid embolus-like syndrome presenting in the second trimester of pregnancy.
    Meier PR; Bowes WA
    Obstet Gynecol; 1983 Mar; 61(3 Suppl):31S-34S. PubMed ID: 6823392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of pre-eclampsia and obstetric outcome in pregnancies of normotensive and hypertensive women attending a hospital specialist clinic.
    Lydakis C; Beevers M; Beevers DG; Lip GY
    Int J Clin Pract; 2001; 55(6):361-7. PubMed ID: 11501223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Termination of pregnancy during the mid-trimester by intra-amniotic injection of urea.
    Greenhalf JO
    Br J Clin Pract; 1972 Jan; 26(1):24-6. PubMed ID: 5025911
    [No Abstract]   [Full Text] [Related]  

  • 17. Decreased serum levels of kisspeptin in early pregnancy are associated with intra-uterine growth restriction and pre-eclampsia.
    Armstrong RA; Reynolds RM; Leask R; Shearing CH; Calder AA; Riley SC
    Prenat Diagn; 2009 Oct; 29(10):982-5. PubMed ID: 19582702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic interruption of pregnancy in the second trimester after preparation of the cervix with prostaglandins F2 alpha].
    Maria B; Stampf F; Barrat J
    J Gynecol Obstet Biol Reprod (Paris); 1983; 12(5):545-52. PubMed ID: 6581224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ancillary staff's functions in the intensive care unit in severe cases of hypertensive toxic pregnancies (pre-eclampsia and eclampsia)].
    Kovács K; Bucur C; Lazăr R
    Munca Sanit; 1973 Feb; 21(2):71-5. PubMed ID: 4489713
    [No Abstract]   [Full Text] [Related]  

  • 20. Are we increasing serious maternal morbidity by postponing termination of pregnancy in severe pre-eclampsia/eclampsia?
    Thomas T; Jophy R; Mhaskar A; Misquith D
    J Obstet Gynaecol; 2005 May; 25(4):347-51. PubMed ID: 16091314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.